- Pakistan 122-1 at lunch in first England Test
- Kazakhs approve plan for first nuclear power plant
- World marks anniversary of Oct. 7 attack on Israel
- 'Second family': tennis stars hunt winning formula with new coaches
- Philippines, South Korea agree to deepen maritime cooperation
- Mexico mayor murdered days after taking office
- Sardinia's sheep farmers battle bluetongue as climate warms
- Japan govt admits doctoring 'untidy' cabinet photo
- Israel marks first anniversary of Hamas's October 7 attack
- Darvish tames Ohtani as Padres thrash Dodgers
- Asian markets track Wall St rally on jobs data
- Family affair as LeBron, Bronny James make Lakers bow
- Cancer, cardiovascular drugs tipped for Nobel as prize week opens
- As Great Salt Lake dries, Utah Republicans pardon Trump climate skepticism
- Amazon activist warns of 'critical situation' ahead of UN forum
- Mourners pay tribute to latest victims of deadly Channel crossing
- Phillies win thriller to level Mets series
- Yu bags first PGA Tour win with playoff win
- PSG held by Nice to leave Monaco clear at top of Ligue 1
- Lewandowski treble for leaders Barca as Atletico held
- Fresh Israeli strikes hit south Beirut
- Sucic stunner earns Real Sociedad draw against Atletico
- PSG draw with Nice, fail to reclaim top spot in Ligue 1
- Gudmundsson downs AC Milan after De Gea's penalty heroics for Fiorentina
- 'Yes' vote prevails in Kazakhstan nuclear plant vote: TV
- 'Difficult day': Oct 7 commemorations begin with festival memorial
- Commemorations begin for anniversary of attack on Israel
- 'Nothing gets in way of team,' says Celtics' MVP hopeful Tatum
- 'We will win!': Mozambique's ruling party confident at final vote rally
- Tunisia voting ends as Saied eyes re-election with critics behind bars
- Florida braces for Milton, FEMA head slams 'dangerous' Helene misinformation
- Postecoglou slams 'unacceptable' Spurs after 'terrible' loss at Brighton
- Marmoush double denies Bayern outright Bundesliga top spot
- Rallies worldwide call for Gaza, Lebanon ceasefire
- New 'Joker' film, a dark musical, tops N.America box office
- Man Utd stalemate keeps Ten Hag in danger, Spurs rocked by Brighton
- Drowned by hurricane, remote N.Carolina towns now struggle for water
- Vikings hold off Jets in London to stay unbeaten
- Ahead of attack anniversary, Netanyahu says: 'We will win'
- West Indies cruise to T20 World Cup win over Scotland
- Man Utd fire another blank in Aston Villa stalemate
- Lewandowski treble powers Liga leaders Barca to Alaves victory
- Russian activist killed on front line in Ukraine
- Openda strike briefly sends Leipzig top of Bundesliga
- Goal-shy Man Utd have to 'step up', says Ten Hag
- India bowl out Bangladesh for 127 in T20 opener
- Madueke rescues Chelsea in draw with 10-man Forest
- Beckett's belief rewarded as Bluestocking storms to Arc glory
- Trump on the stump, Harris hits airwaves in razor-edge US election
- Flash flooding kills three in northern Thailand
US approves Covid vaccines for youngest kids
US health authorities on Saturday cleared the Pfizer and Moderna Covid-19 vaccines for children aged five and younger, in a move President Joe Biden greeted as a "monumental step" in the fight against the virus.
The United States thus became the first country to approve use of the so-called mRNA vaccines for children as young as six months.
The US Food and Drug Administration (FDA) had on Friday authorized their emergency use for young children -- who previously had to be at least five to receive the vaccine.
But the vaccines required further clearance from the US Centers for Disease Control and Prevention (CDC), the country's leading public health agency -- and they received that on Saturday.
"We know millions of parents and caregivers are eager to get their young children vaccinated, and with today's decision, they can," CDC Director Rochelle Walensky said in a statement Saturday.
Once the green light was received from the FDA, the US government began distributing millions of doses of the vaccine across the country.
Biden promised that parents could begin scheduling appointments as early as next week to have their young children vaccinated at hospitals, clinics, pharmacies and doctor's offices.
In a statement Saturday, he touted the vaccines as "safe (and) highly effective," and said that "for parents all over the country, this is a day of relief and celebration."
In coming weeks, with more and more doses shipped out, "every parent who wants a vaccine will be able to get one," he said.
The Moderna vaccine, administered in two doses a month apart, will be available to children aged six months to five years in reduced doses of 25 micrograms (half the amount given children aged six to 11, and a quarter the dose for those 12 and older).
The Pfizer-BioNTech vaccine is now authorized for children aged six months to four years, and will be given in doses of three micrograms per injection -- one-tenth the adult dosage.
The difference, however, is that children will receive three shots -- the first two three weeks apart, followed by a third eight weeks later.
So, children receiving it will not have full protection for the first few months.
Its side effects, however, have appeared less serious in drug trials than those of the Moderna vaccine.
About a quarter of young children receiving Moderna have developed fevers, particularly after the second dose -- but they generally lasted no more than a day.
About 20 million US children are now eligible, by age, for the new vaccines.
While children have generally proved less vulnerable to Covid-19, some 480 in the US in this age group have died of the virus.
So-called long Covid is also a concern, as is multisystem inflammatory syndrome, a rare but serious post-viral condition.
Pfizer has said it hopes to apply in early July to the European Medicines Agency for authorization to provide its vaccines to children in this youngest age group.
A.Silveira--PC